T1	Participants 70 95	early-stage breast cancer
T2	Participants 166 202	women with early-stage breast cancer
T3	Participants 255 294	clinical trial of a sample of 125 women
T4	Participants 300 318	experimental group
T5	Participants 575 593	experimental group
